Insider Purchase: Jeffrey Busch Invested in 6,000 Shares of Global Medical REIT Inc. (GMRE); Misonix (MSON) Has 8 Sentiment

Misonix, Inc., together with its subsidiaries, designs, develops, makes, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company has market cap of $94.03 million. The firm offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. It currently has negative earnings. The Company’s products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications.

Jeffrey Busch who is the acting Chairman – President and CEO of Global Medical Reit Inc recently bought 6,000 shares of the Quebec – Canada-based company. The new insider transaction has $42,760 US Dollars total value, at an average price-per-share of $7.1. This insider purchase, was completed on 13-03-2018. It’s ready for use online at the SEC’s website and can be found at this page. Presently, Jeffrey Busch owns 28,740 shares which are equivalent to roughly 0.13% of the Company’s market cap.

The stock decreased 0.50% or $0.05 during the last trading session, reaching $10. About 3,013 shares traded. Misonix, Inc. (MSON) has risen 145.17% since March 14, 2017 and is uptrending. It has outperformed by 128.47% the S&P500.

Since January 1, 0001, it had 4 buys, and 0 selling transactions for $69,529 activity.

Wealthtrust Axiom Llc holds 0.27% of its portfolio in Misonix, Inc. for 70,345 shares. Bridgeway Capital Management Inc owns 54,800 shares or 0.01% of their US portfolio. Moreover, Rathbone Brothers Plc has 0.01% invested in the company for 14,600 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 17,828 shares.

Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The company has market cap of $158.87 million. The Company's strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market-leading operators under long-term triple-net leases. It currently has negative earnings. The Company's management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers.

Among 6 analysts covering Global Medical.. (NYSE:GMRE), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Global Medical.. has $12.0 highest and $10.5 lowest target. $11.42’s average target is 58.39% above currents $7.21 stock price. Global Medical.. had 9 analyst reports since July 11, 2016 according to SRatingsIntel. The company was initiated on Thursday, August 31 by Cantor Fitzgerald. The rating was downgraded by Compass Point on Tuesday, September 20 to “Neutral”. The firm earned “Buy” rating on Monday, July 11 by Wunderlich. The stock has “Neutral” rating by DA Davidson on Tuesday, August 22. On Monday, July 11 the stock rating was initiated by Compass Point with “Buy”. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, November 13 report. On Monday, July 11 the stock rating was initiated by BB&T Capital with “Hold”.

The stock increased 1.12% or $0.08 during the last trading session, reaching $7.21. About 261,932 shares traded or 19.20% up from the average. Global Medical REIT Inc. (NYSE:GMRE) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.